cAMP-化酶4D7 (PDE4D7) 与DHX9形成一个cAMP信号体复合体,并与前列腺癌进展有关
Chloe Gulliver1, Tara Busiau1, Ashleigh Byrne1
1School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Science, University of Glasgow, UK.
Molecular oncology
|December 21, 2023
概括
减少固酶4D7 (PDE4D7) 蛋白质的水平与前列腺癌 (PCa) 的不良结果有关. 这项研究确定了一种PDE4D7-DHX9蛋白质复合物,该复合物驱动瘤生长,提供了一个潜在的治疗标.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 降低的固酶4D异型7 (PDE4D7) 水平与不良前列腺癌 (PCa) 结果相关.
- 在ERG融合阳性PCa中PDE4D基因的超甲基化抑制了mRNA表达和PDE4D7蛋白质的产生.
- 将PDE4D7减缓与PCa进展联系在一起的精确分子机制尚不清楚.
研究的目的:
- 阐明PDE4D7降低和PCa之间的关系的分子机制.
- 确定与PDE4D7相互作用的蛋白质,并了解它们在PCa中异常cAMP信号传递中的作用.
- 探索PDE4D7-DHX9复合体作为治疗点的潜力.
主要方法:
- PDE4D7的免疫净化,然后进行质谱测量以确定结合伙伴.
- 配列技术和近距离结合试验验证PDE4D7-DHX9相互作用.
- 设计和测试一种针对PDE4D7-DHX9复合体的新干扰剂.
主要成果:
- PDE4D7与依赖ATP的RNA酶A (DHX9) 形成了一个新的信号复合体.
- 干扰PDE4D7-DHX9复合体显著降低了LNCaP前列腺癌细胞的增殖.
- 通过PDE4D7调节的DHX9上发现了一个新的蛋白激酶A (PKA) 酸化位.
结论:
- 一个以前未被识别的PDE4D7-DHX9信号复合体在前列腺癌的发病过程中起着至关重要的作用.
- 这种复合体代表了前列腺癌治疗的潜在新型治疗标.
- 了解PDE4D7对DHX9酸化部位的调节可能会提供进一步的治疗见解.
相关概念视频
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


